Alembic Pharma Results Dec 2022 (Standalone_YoY) revenue elevated to 1310.2 crores up 6.3% in Dec 2022 quarter, compared with 1232.8 crores in Dec 2021. Its Net profit is 119.1 crores down -38.5% in Dec 2022 quarter, compared with 193.6 crores in last year same quarter. Please click Image for Results of the stock.
Click Image for Data | Scroll down for Comments
Results Declared Stocks 2022 Dec
Stock market Data of India from NSE/BSE.
* Data is Only for educational purpose, not for trading.
* Consult your financial advisor before trading or investing in any stock.
Download : InvestinStocks-Data app from Google Play Store